Phenotype and gene expression pattern of osteoblast-like cells cultured on polystyrene and hydroxyapatite with pre-adsorbed type-I collagen

Journal of Biomedical Materials Research - Part A

Volumn 83, Issue 2, 2007, Pages 362-371

  Hanagata, Nobutaka ^a   Takemura, Taro ^a   Monkawa, Akira ^a   Ikoma, Toshiyuki ^a   Tanaka, Junzo ^b  

^a NATIONAL INSTITUTE FOR MATERIALS SCIENCE   (Japan)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Gene expression; Hydroxyapatite; Mineralization; Osteoblast; Type I collagen

Indexed keywords

ADSORPTION; GENE EXPRESSION; HYDROXYAPATITE; POLYSTYRENES;

MINERALIZATION; OSTEOBLAST; TYPE-I COLLAGEN;

CELLS;

ALPHA2 INTEGRIN; ALPHA5 INTEGRIN; CALCIUM CHANNEL L TYPE; COLLAGEN TYPE 1; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYDROXYAPATITE; INTEGRIN; OSTEOCLAST DIFFERENTIATION FACTOR; POLYSTYRENE;

ANIMAL CELL; ARTICLE; BONE MINERALIZATION; CELL ADHESION; CELL CULTURE; CELL MATURATION; CELL SPREADING; CELL STRUCTURE; CONTROLLED STUDY; DNA MICROARRAY; GENE; GENE EXPRESSION; HISTOCHEMISTRY; IMMUNOFLUORESCENCE; LFITM5 GENE; LY6A GENE; MOUSE; NONHUMAN; OSTEOBLAST; PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TMEM37 GENE;

ADSORPTION; ANIMALS; CALCIFICATION, PHYSIOLOGIC; CELL ADHESION; CELL SHAPE; CELLS, CULTURED; CLUSTER ANALYSIS; COLLAGEN TYPE I; DURAPATITE; GENE EXPRESSION REGULATION; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOBLASTS; OSTEOGENESIS; PHENOTYPE; POLYSTYRENES; SOLUTIONS;

EID: 35048838734     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31240     Document Type: Article

References (31)

1. Steele JG, McFarland C, Dalton BA, Johnson G, Evans MD, Howlett CR, Underwood PA. Attachment of human bone cells to tissue culture polystyrene and to unmodified polystyrene: The effect of surface chemistry upon initial cell attachment. J Biomater Sci Polym Ed 1993;5:245-257.
2. Howlett CR, Evans MD, Walsh WR, Johnson G, Steele JG. Mechanism of initial attachment of cells derived from human bone to commonly used prosthetic materials during cell culture. Biomaterials 1994;15:213-222.
3. Kilpadi KL, Chang PL, Bellis SL. Hydroxyapatite binds more serum proteins, purified integrins, and osteoblast precursor cells than titanium or steel. J Biomed Mater Res 2001;57:258-267.
4. Schneider G, Burridge' K. Formation of focal adhesions by osteoblasts adhering to different substrata. Exp Cell Res 1994;214:264-269.
5. Degasne I, Basle MF, Demais V, Hure G, Lesourd M, Grolleau B, Mercier L, Chappard D. Effects of roughness, fibronectin and vitronectin on attachment, spreading, and proliferation of human osteoblast-like cells (Saos-2) on titanium surfaces. Calcif Tissue Int 1999;64:499-507.
6. Hanagata N, Takemura T, Monkawa A, Ikoma T, Tanaka J. Pre-adsorbed type-I collagen structure-dependent changes in osteoblastic phenotype. Bioehem Biophys Res Commun 2006;344:1234-1240.
7. Garcia AJ, Vega MD, Boettiger D. Modulation of cell proliferation and differentiation through substrate-dependent changes in fibronectin conformation. Mol Biol Cell 1999;10:785-798.
8. Stephansson SN, Byers BA, Garcia AJ. Enhanced expression of the osteoblastic phenotype on substrates that modulate fibronectin conformation and integrin receptor binding. Biomaterials 2002;23:2527-2534.
9. Ikoma T, Yamazaki A, Nakamura S, Akao M. Preparation and dielectric property of sintered monoclinic hydroxyapatite. J Mater Sci Lett 1999;18:1225-1228.
10. Akisaka T, Gay CV. The plasma membrane and matrix vesicles of mouse growth plate chondrocytes during differentiation as revealed in freeze-fracture replicas. Am J Anat 1985;173:269-286.
11. Anderson HC. Molecular biology of matrix vesicles. Clin Orthop Res 1995;314:266-280.
12. Boskey AL, Boyan BD, Schwartz Z. Matrix vesicles promote mineralization in a gelatin gel. Calcif Tissue Int 1997;60:309-315.
13. De Vernejoul MC. Dynamics of bone remodeling: Biochemical and pathophysiological basis. Eur Clin Chem Clin Biochem 1996;34:729-734.
14. Bergh JJ, Xu Y, Farach-carson MC. Osteoprotegerin expression and secretion are regulated by calcium influx through the L-type voltage-sensitive calcium channel. Endocrinology 2004;145:426-436.
15. Hakim FT, Cranley R, Brown KS, Eanes ED, Harne L, Oppenheim JJ. Hereditary joint disorder in progressive ankylosis (ank/ank) mice. I. Association of calcium hydroxyapatite deposition with inflammatory arthropathy. Arthritis Rheum 1994;27:1411-1420.
16. Ho AM, Johnson MD, Kingsley DM. Role of mouse ank gene in control of tissue calcification and arthritis. Science 2000;289:265-269.
17. Terkeltaub R, Rosenbach M, Fong F, Goding J. Causal link between nucleotide pyrophosphohydrolase overactivity and increased intracellular inorganic pyrophosphate generation demonstrated by transfection of cultured fibroblasts and osteoblasts with plasma cell membrane glycoprotein-1. Arthritis Rheum 1994;37:934-941.
18. Johnson K, Moffa A, Chen Y, Pritzker K, Goding J, Terkeltaub R. Matrix vesicle plasma membrane glycoprotein-1 regulates mineralization by murine osteoblastic cells. J Bone Miner Res 1994;14:883-892.
19. Johnson K, Vaingankar S, Chen Y, Moffa A, Goldring M, Sano K, Jin-Hua P, Sali A, Goding J, Terkeltaub R. Differential mechanisms of inorganic pyrophosphate production by plasma cell membrane glycoprotein-1 and B10 in chondrocytes. Arthritis Rheum 1999;42:1986-1997.
20. Moss DW, Eaton RH, Smith JK, Whitby LG. Association of inorganic-pyrophosphatase activity with human alkaline-phosphatase preparation. Biochem J 1967;102:53-57.
21. Majeska RJ, Wuthier RE. Studies on matrix vesicles isolated from chick epiphyseal cartilage. Association of pyrophosphatase and ATPase activities with alkaline phosphatase. Biochim Biophys Acta 1975;391:51-60.
22. Meyer JL. Studies on matrix vesicles isolated from chick epiphyseal cartilage. Association of pyrophosphatase and ATPase activities with alkaline phosphatase. Arch Biochem Biophys 1984;231:1-8.
23. Rezende A, Pizauro J, Ciancaglini P, Leone F. Phosphodiesterase activity is a novel property of alkaline phosphatase from osseous plate. Bioehem J 1994;301:517-522.
24. Hessle L, Johnson KA, Anderson HC, Narisawa S, Sali A, Goding JW, Terkeltaub R, Millan JL. Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci USA 2002;99:9445-9449.
25. Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Smith E, Bonadio J, Goldstein S, Gundberg C, Bradley A, Karsenty G. Increased bone formation in osteocalcin-deficient mice. Nature 1996;382:448-452.
26. Romberg RW, Werness PG, Riggs BL, Mann KG. Inhibition of hydroxyapatite crystal growth by bone-specific and other calcium-binding proteins. Biochemistry 1986;25:1176-1180.
27. Ameye L, Aria D, Jepsen K, Oldberg A, Xu T, Young MF. Abnormal collagen fibrils in tendons of bigycan/fibromodulin-deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis. FASEB J 2002;16:673-680.
28. Corsi A, Xu T, Chen XD, Boy de A, Liang J, Mankani M, Sommer B, Iozzo RV, Eichstetter I, Gehron PR, Bianco P, Young M. Phenotypic effect of biglycan are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues. J Bone Miner Res 2002;17:1180-1189.
29. Xu T, Bianco P, Fisher L, Longenecker G, Smith E, Goldstein S, Bonadio J, Boskey A, Heegaard A, Sommer B, Satomura K, Dominguez P, Zhao C, Kulkarni A, Gehron-Robey P, Young M. Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat Genet 1998;20:78-82.
30. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 1997;89:309-319.
31. Bonyadi M, Waldman SD, Liu D, Aubin JE, Grynpas MD, Stanford WL. Mesenchymal projenitor self-renewal deficiency leads to age-dependent osteoporosis in Sca-1/Ly6A null mice. Proc Natl Acad Sci USA 2003;100:5840-5845.